Yes, it does. The evidence supporting hormone therapy as a meaningful, life-changing treatment for transgender people is robust and consistent. When people receive hormones that align with their gender identity, their psychological wellbeing, life satisfaction, and overall quality of life improve in ways that are both measurable and profound.
What the Evidence Actually Says
The WPATH Standards of Care, Version 8, published in 2022, draws on decades of clinical evidence to confirm that gender-affirming hormone therapy reduces gender dysphoria and improves mental health outcomes, including reductions in depression, anxiety, and suicidal ideation. The Endocrine Society guidelines, updated in 2017, similarly support hormone therapy as a medically necessary treatment, not an optional or cosmetic one, for transgender adults and adolescents where clinically appropriate. These are not fringe positions. They represent the international consensus of endocrinologists, psychiatrists, and gender medicine specialists who have spent careers studying this field.
Why Hormones Matter So Much
For many transgender people, the distress caused by living in a body whose hormonal profile does not match their gender identity is significant and ongoing. It affects how they see themselves in the mirror, how they feel in social situations, and how they experience their own body day to day. Hormone therapy works by aligning the body's hormonal environment with a person's gender identity, and that alignment matters deeply. It is not simply about physical changes, though those changes are important. It is about congruence: the sense of finally living in a body that feels like yours.
Mental Health and Hormone Therapy
The improvements in mental health that follow hormone therapy are well-documented. Rates of depression and anxiety fall. Self-esteem improves. The persistent background distress that many transgender people describe, often for years before accessing treatment, begins to lift. This is why organisations including the NHS recognise hormone therapy as part of an established treatment pathway for gender dysphoria. Denying or delaying access to this treatment does not protect people. It prolongs suffering that is both unnecessary and preventable.